{
    "matches": [
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Fibrinogen beta chain isoform 1 pre-pro-protein",
                    "accession": "70906435",
                    "MW (kDa)": "56",
                    "average SC in cancer": "138.8",
                    "average SC in control": "52.1",
                    "NSAF ratio": "2.2",
                    "statistical test": "t-test",
                    "P-value": "0.01481"
                },
                "measures": "[average SC in cancer, average SC in control, NSAF ratio, P-value]",
                "outcomes": "[138.8, 52.1, 2.2, 0.01481]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Fibrinogen beta chain isoform 1 pre-pro-protein",
                    "accession": "70906435",
                    "Molecural weight (MW) (kDa)": "56",
                    "statistical test": "t-test"
                },
                "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                "outcomes": "[138.8, 52.1, 2.2, 0.01481]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "C4b-binding protein alpha chain precursor",
                    "accession": "4502503",
                    "MW (kDa)": "67",
                    "average SC in cancer": "37.3",
                    "average SC in control": "11.5",
                    "NSAF ratio": "2.3",
                    "statistical test": "t-test",
                    "P-value": "0.04311"
                },
                "measures": "[average SC in cancer, average SC in control, NSAF ratio, P-value]",
                "outcomes": "[37.3, 11.5, 2.3, 0.04311]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "C4b-binding protein alpha chain precursor",
                    "accession": "4502503",
                    "Molecural weight (MW) (kDa)": "67",
                    "statistical test": "t-test"
                },
                "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                "outcomes": "[37.3, 11.5, 2.3, 0.04311]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Serum albumin pre-pro-protein",
                    "accession": "4502027",
                    "MW (kDa)": "69",
                    "average SC in cancer": "986.0",
                    "average SC in control": "332.8",
                    "NSAF ratio": "2.4",
                    "statistical test": "t-test",
                    "P-value": "0.00006"
                },
                "measures": "[average SC in cancer, average SC in control, NSAF ratio, P-value]",
                "outcomes": "[986.0, 332.8, 2.4, 0.00006]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Serum albumin pre-pro-protein",
                    "accession": "4502027",
                    "Molecural weight (MW) (kDa)": "69",
                    "statistical test": "t-test"
                },
                "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                "outcomes": "[986.0, 332.8, 2.4, 0.00006]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Vitamin D-binding protein isoform 1 precursor",
                    "accession": "32483410",
                    "MW (kDa)": "53",
                    "average SC in cancer": "51.9",
                    "average SC in control": "19.2",
                    "NSAF ratio": "2.4",
                    "statistical test": "t-test",
                    "P-value": "0.03919"
                },
                "measures": "[average SC in cancer, average SC in control, NSAF ratio, P-value]",
                "outcomes": "[51.9, 19.2, 2.4, 0.03919]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Vitamin D-binding protein isoform 1 precursor",
                    "accession": "32483410",
                    "Molecural weight (MW) (kDa)": "53",
                    "statistical test": "t-test"
                },
                "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                "outcomes": "[51.9, 19.2, 2.4, 0.03919]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Kininogen-1 isoform 2 precursor",
                    "accession": "4504893",
                    "MW (kDa)": "48",
                    "average SC in cancer": "21.3",
                    "average SC in control": "5.5",
                    "NSAF ratio": "3.8",
                    "statistical test": "t-test",
                    "P-value": "0.01109"
                },
                "measures": "[average SC in cancer, average SC in control, NSAF ratio, P-value]",
                "outcomes": "[21.3, 5.5, 3.8, 0.01109]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Kininogen-1 isoform 2 precursor",
                    "accession": "4504893",
                    "Molecural weight (MW) (kDa)": "48",
                    "statistical test": "t-test"
                },
                "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                "outcomes": "[21.3, 5.5, 3.8, 0.01109]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Alpha-2-macroglobulin precursor",
                    "accession": "66932947",
                    "MW (kDa)": "163",
                    "average SC in cancer": "127.9",
                    "average SC in control": "29.3",
                    "NSAF ratio": "3.9",
                    "statistical test": "t-test",
                    "P-value": "0.00618"
                },
                "measures": "[average SC in cancer, average SC in control, NSAF ratio, P-value]",
                "outcomes": "[127.9, 29.3, 3.9, 0.00618]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Alpha-2-macroglobulin precursor",
                    "accession": "66932947",
                    "Molecural weight (MW) (kDa)": "163",
                    "statistical test": "t-test"
                },
                "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                "outcomes": "[127.9, 29.3, 3.9, 0.00618]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Haptoglobin isoform 1 pre-pro-protein",
                    "accession": "4826762",
                    "MW (kDa)": "45",
                    "average SC in cancer": "83.8",
                    "average SC in control": "18.0",
                    "NSAF ratio": "4.2",
                    "statistical test": "t-test",
                    "P-value": "0.00024"
                },
                "measures": "[average SC in cancer, average SC in control, NSAF ratio, P-value]",
                "outcomes": "[83.8, 18.0, 4.2, 0.00024]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Haptoglobin isoform 1 pre-pro-protein",
                    "accession": "4826762",
                    "Molecural weight (MW) (kDa)": "45",
                    "statistical test": "t-test"
                },
                "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                "outcomes": "[83.8, 18.0, 4.2, 0.00024]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Fibrinogen gamma chain isoform gamma-B precursor",
                    "accession": "70906439",
                    "MW (kDa)": "52",
                    "average SC in cancer": "89.3",
                    "average SC in control": "17.3",
                    "NSAF ratio": "4.3",
                    "statistical test": "t-test",
                    "P-value": "0.00133"
                },
                "measures": "[average SC in cancer, average SC in control, NSAF ratio, P-value]",
                "outcomes": "[89.3, 17.3, 4.3, 0.00133]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Fibrinogen gamma chain isoform gamma-B precursor",
                    "accession": "70906439",
                    "Molecural weight (MW) (kDa)": "52",
                    "statistical test": "t-test"
                },
                "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                "outcomes": "[89.3, 17.3, 4.3, 0.00133]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Complement C3 precursor",
                    "accession": "115298678",
                    "MW (kDa)": "187",
                    "average SC in cancer": "174.7",
                    "average SC in control": "35.6",
                    "NSAF ratio": "4.3",
                    "statistical test": "t-test",
                    "P-value": "0.00612"
                },
                "measures": "[average SC in cancer, average SC in control, NSAF ratio, P-value]",
                "outcomes": "[174.7, 35.6, 4.3, 0.00612]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Complement C3 precursor",
                    "accession": "115298678",
                    "Molecural weight (MW) (kDa)": "187",
                    "statistical test": "t-test"
                },
                "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                "outcomes": "[174.7, 35.6, 4.3, 0.00612]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Myeloperoxidase precursor",
                    "accession": "4557759",
                    "MW (kDa)": "84",
                    "average SC in cancer": "70.2",
                    "average SC in control": "11.0",
                    "NSAF ratio": "5.3",
                    "statistical test": "t-test",
                    "P-value": "0.02501"
                },
                "measures": "[average SC in cancer, average SC in control, NSAF ratio, P-value]",
                "outcomes": "[70.2, 11.0, 5.3, 0.02501]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Myeloperoxidase precursor",
                    "accession": "4557759",
                    "Molecural weight (MW) (kDa)": "84",
                    "statistical test": "t-test"
                },
                "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                "outcomes": "[70.2, 11.0, 5.3, 0.02501]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Apolipoprotein A-I pre-pro-protein",
                    "accession": "4557321",
                    "MW (kDa)": "31",
                    "average SC in cancer": "29.8",
                    "average SC in control": "5.9",
                    "NSAF ratio": "5.7",
                    "statistical test": "t-test",
                    "P-value": "0.02170"
                },
                "measures": "[average SC in cancer, average SC in control, NSAF ratio, P-value]",
                "outcomes": "[29.8, 5.9, 5.7, 0.02170]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Apolipoprotein A-I pre-pro-protein",
                    "accession": "4557321",
                    "Molecural weight (MW) (kDa)": "31",
                    "statistical test": "t-test"
                },
                "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                "outcomes": "[29.8, 5.9, 5.7, 0.02170]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Fibrinogen alpha chain isoform alpha-E pre-pro-protein",
                    "accession": "4503689",
                    "MW (kDa)": "95",
                    "average SC in cancer": "63.3",
                    "average SC in control": "9.3",
                    "NSAF ratio": "6.4",
                    "statistical test": "t-test",
                    "P-value": "0.00031"
                },
                "measures": "[average SC in cancer, average SC in control, NSAF ratio, P-value]",
                "outcomes": "[63.3, 9.3, 6.4, 0.00031]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Fibrinogen alpha chain isoform alpha-E pre-pro-protein",
                    "accession": "4503689",
                    "Molecural weight (MW) (kDa)": "95",
                    "statistical test": "t-test"
                },
                "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                "outcomes": "[63.3, 9.3, 6.4, 0.00031]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Alpha-2-HS-glycoprotein pre-pro-protein",
                    "accession": "156523970",
                    "MW (kDa)": "39",
                    "average SC in cancer": "7.3",
                    "average SC in control": "1.1",
                    "NSAF ratio": "6.5",
                    "statistical test": "t-test",
                    "P-value": "0.00173"
                },
                "measures": "[average SC in cancer, average SC in control, NSAF ratio, P-value]",
                "outcomes": "[7.3, 1.1, 6.5, 0.00173]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Alpha-2-HS-glycoprotein pre-pro-protein",
                    "accession": "156523970",
                    "Molecural weight (MW) (kDa)": "39",
                    "statistical test": "t-test"
                },
                "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                "outcomes": "[7.3, 1.1, 6.5, 0.00173]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Ceruloplasmin precursor",
                    "accession": "4557485",
                    "MW (kDa)": "122",
                    "average SC in cancer": "47.3",
                    "average SC in control": "5.6",
                    "NSAF ratio": "7.5",
                    "statistical test": "t-test",
                    "P-value": "0.00114"
                },
                "measures": "[average SC in cancer, average SC in control, NSAF ratio, P-value]",
                "outcomes": "[47.3, 5.6, 7.5, 0.00114]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Ceruloplasmin precursor",
                    "accession": "4557485",
                    "Molecural weight (MW) (kDa)": "122",
                    "statistical test": "t-test"
                },
                "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                "outcomes": "[47.3, 5.6, 7.5, 0.00114]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "PREDICTED: complement C4-A isoform 1",
                    "accession": "341916194",
                    "MW (kDa)": "193",
                    "average SC in cancer": "32.1",
                    "average SC in control": "4.5",
                    "NSAF ratio": "7.7",
                    "statistical test": "t-test",
                    "P-value": "0.01791"
                },
                "measures": "[average SC in cancer, average SC in control, NSAF ratio, P-value]",
                "outcomes": "[32.1, 4.5, 7.7, 0.01791]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "PREDICTED: complement C4-A isoform 1",
                    "accession": "341916194",
                    "Molecural weight (MW) (kDa)": "193",
                    "statistical test": "t-test"
                },
                "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                "outcomes": "[32.1, 4.5, 7.7, 0.01791]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Alpha-1B-glycoprotein precursor",
                    "accession": "21071030",
                    "MW (kDa)": "54",
                    "average SC in cancer": "10.9",
                    "average SC in control": "1.2",
                    "NSAF ratio": "8.3",
                    "statistical test": "t-test",
                    "P-value": "0.00468"
                },
                "measures": "[average SC in cancer, average SC in control, NSAF ratio, P-value]",
                "outcomes": "[10.9, 1.2, 8.3, 0.00468]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Alpha-1B-glycoprotein precursor",
                    "accession": "21071030",
                    "Molecural weight (MW) (kDa)": "54",
                    "statistical test": "t-test"
                },
                "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                "outcomes": "[10.9, 1.2, 8.3, 0.00468]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Inter-alpha-trypsin inhibitor heavy chain H4 isoform 1 precursor",
                    "accession": "31542984",
                    "MW (kDa)": "103",
                    "average SC in cancer": "5.5",
                    "average SC in control": "0.2",
                    "NSAF ratio": "35.4",
                    "statistical test": "t-test",
                    "P-value": "0.00484"
                },
                "measures": "[average SC in cancer, average SC in control, NSAF ratio, P-value]",
                "outcomes": "[5.5, 0.2, 35.4, 0.00484]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Inter-alpha-trypsin inhibitor heavy chain H4 isoform 1 precursor",
                    "accession": "31542984",
                    "Molecural weight (MW) (kDa)": "103",
                    "statistical test": "t-test"
                },
                "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                "outcomes": "[5.5, 0.2, 35.4, 0.00484]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Apolipoprotein B-100 precursor",
                    "accession": "105990532",
                    "MW (kDa)": "516",
                    "average SC in cancer": "49.3",
                    "average SC in control": "1.0",
                    "NSAF ratio": "55.7",
                    "statistical test": "t-test",
                    "P-value": "0.02595"
                },
                "measures": "[average SC in cancer, average SC in control, NSAF ratio, P-value]",
                "outcomes": "[49.3, 1.0, 55.7, 0.02595]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "analysis": "Proteins identified as more abundant in cancer (malignant strictures) than in controls (primary sclerosing cholangitis and benign strictures)",
                    "protein": "Apolipoprotein B-100 precursor",
                    "accession": "105990532",
                    "Molecural weight (MW) (kDa)": "516",
                    "statistical test": "t-test"
                },
                "measures": "[Average Spectral Count (SC)(Cancer), Average Spectral Count (SC)(Control), Normalized Spectral Abundance Factor (NSAF) ratio, P-value]",
                "outcomes": "[49.3, 1.0, 55.7, 0.02595]"
            },
            "match": "yes"
        }
    ],
    "total_extracted_claims": 18,
    "total_ground_truth_claims": 18,
    "number_of_matches": 18
}